DOXIL is a Intravenous Injection, Suspension, Liposomal in the Human Prescription Drug category. It is labeled and distributed by Janssen Products, Lp. The primary component is Doxorubicin Hydrochloride.
Product ID | 59676-960_17206b15-725c-410d-838d-ccb228c6ea2b |
NDC | 59676-960 |
Product Type | Human Prescription Drug |
Proprietary Name | DOXIL |
Generic Name | Doxorubicin Hydrochloride |
Dosage Form | Injection, Suspension, Liposomal |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 1995-11-17 |
Marketing Category | NDA / NDA |
Application Number | NDA050718 |
Labeler Name | Janssen Products, LP |
Substance Name | DOXORUBICIN HYDROCHLORIDE |
Active Ingredient Strength | 2 mg/mL |
Pharm Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [CS],Topoisomerase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 1995-11-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050718 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1995-11-17 |
Marketing End Date | 2020-06-30 |
Marketing Category | NDA |
Application Number | NDA050718 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1995-11-17 |
Marketing End Date | 2020-09-30 |
Ingredient | Strength |
---|---|
DOXORUBICIN HYDROCHLORIDE | 2 mg/mL |
SPL SET ID: | 21d9c619-7e94-49e2-ac41-31e9ea96554a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
59676-960 | DOXIL | DOXIL |
0338-0063 | DOXIL | DOXIL |
0338-0067 | DOXIL | DOXIL |
0069-3030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
0069-3031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
0069-3032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
0069-3033 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
0069-3034 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
0069-4004 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
0069-4015 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
0069-4026 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DOXIL 74223789 1744235 Live/Registered |
BAXTER HEALTHCARE CORPORATION 1991-11-21 |